Drug Discovery World

FEBRUARY 26, 2024

Reece Armstrong speaks to Kathryn Golden , SVP Technical Operations and Manufacturing, bit.bio, about novel technologies, and methods to manufacture human cells for therapies so more patients can access these treatments. Cell therapies have emerged as transformative and potentially curative treatments across a range of disease areas.

Therapies 130

Therapies Treatment Engineering Disease 130

Drug Discovery World

JULY 1, 2024

billion DKK ($11.97 billion) in 2023, 51% higher than 2022, marking the company’s largest annual net profit going back to 1989, according to data from S&P Global Market Intelligence 1. When this was launched in September 2021, it was supported by a grant of up to $47.5 million).

Disease 162

Disease International Research Science 162

The Pharma Data

NOVEMBER 11, 2020

and EU5 by 2026. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com. The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.

Therapies 40

Therapies Marketing Disease Clinical Research 40

The Pharma Data

DECEMBER 16, 2020

and EU5 by 2026. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com. The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.

Therapies 40

Therapies Marketing Disease Clinical Research 40

The Pharma Data

OCTOBER 14, 2020

Pre-clinical and clinical proof-of-concept data from a first-in-human single dose DSR study demonstrated that single dose DSR therapy was safe and well-tolerated and the positive results were published in the high impact peer-reviewed cardiovascular journal, Circulation. and EU5 by 2026.

Clinical Trials 40

Clinical Trials Clinical Research Therapies FDA 40

Drug Discovery World

FEBRUARY 22, 2024

There is now hope that new treatments will arise to overcome the limitations of existing therapies and relieve the millions of patients suffering worldwide 4 ”. The report also highlights that the global neuroscience market (GNM) “was worth $612 billion in 2022 and could grow to $721 billion by 2026.

Drugs 147

Drugs Clinical Trials Disease Therapies 147